• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Up and Coming

Up and Coming

April 26, 2021

This feature highlights changes in clinical trial organizations’ personnel.

Amarin

Amarin has promoted Karim Mikhail from senior vice president and commercial head to CEO. Mikhail previously served as CEO of Theodon.

Arcellx

Christopher Heery has been named chief medical officer of clinical-stage biopharmaceutical company Arcellx. Heery is the former chief medical officer at Precision Biosciences.

Atriva Therapeutics

Stephan Stenglein, former head of late-stage development at AstraZeneca, has been named chief medical officer at Atriva Therapeutics.

Castle Creek Biosciences

Matthew Gantz has taken over Castle Creek Biosciences as its newest CEO. Gantz was formerly the CEO of OxThera AB.

Catapult Therapeutics

Dominik Höchli has been named CEO of Catapult Therapeutics. Höchli was most recently vice president and head of global medical affairs at AbbVie.

Cellphire Therapeutics

Michael Gaffney has taken the helm of Cellphire Therapeutics as its newest CEO. Previously, Gaffney was founder and managing director of consulting business Bancroft Group.

Cerevel Therapeutics

Abraham Ceesay has been named president of Cerevel Therapeutics. Ceesay previously served as the CEO of Tiburio Therapeutics.

Dewpoint Therapeutics

Isaac Klein has been named chief scientific officer at Dewpoint Therapeutics. Klein is a former researcher at the Whitehead Institute of the Massachusetts Institute of Technology.

Enveda Biosciences

Enveda Biosciences has hired Sotirios Karathanasis to take on the role of chief scientific officer. Karathanasis previously served as chief scientific officer at Lilly Research Laboratories.

Everest Medicines

Everest Medicines has hired Jennifer Yang to take on the position of chief scientific officer. Yang previously served as vice president and head of China for Johnson & Johnson’s Lung Cancer Initiative.

Gossamer Bio

Gossamer Bio has promoted Laura Carter from senior vice president of research and translational biology to chief scientific officer.

HepaTx

HepaTx has tapped Salah Kivlighn to take on the role of CEO. Kivlighn previously served as senior vice president and head of global marketing at U.S. Pharmacopeia.

Humanigen

Humanigen has appointed Adrian Kilcoyne to chief medical officer. Previously, Kilcoyne served as vice president of oncology global medical affairs and head of evidence generation and external alliances for AstraZeneca.

ImCheck Therapeutics

Loui Madakamutil has been named chief scientific officer of ImCheck Therapeutics. Madakamutil is the former chief scientific officer of Invivoscribe Therapeutics.

Juniper Biologics

Raman Singh has been named CEO at Juniper Biologics. Previously, Singh served as CEO of Mundipharma.

Medicenna Therapeutics

Kevin Moulder, former chief operating officer at PolyProx Therapeutics, has been named the new chief scientific officer of Medicenna Therapeutics.

NKGen Biotech

Steven Cha, former vice president of oncology at Samumed, has been named the new chief medical officer at NKGen Biotech.

Precision BioSciences

Alan List, former CEO of Moffitt Cancer Center, has been named the new chief medical officer of Precision BioSciences.

Protara Therapeutics

Protara Therapeutics has appointed Martín Sebastian Olivo to chief medical officer. Olivo previously served as vice president of breast cancer clinical development at Gilead Sciences.

Quercis Pharma

John Boghossian has been named CEO of Quercis Pharma. Boghossian is the former director of Pangea Botanica and vice president of operations at Compass Pathways.

Sitryx

Sitryx has appointed Iain Kilty to chief scientific officer. Previously, Kilty was the chief scientific officer at Quench Bio.

Sutro Biopharma

Sutro Biopharma has promoted Trevor Hallam from chief scientific officer to president of research. Hallam served as executive vice president of research and development at Palatin Technologies prior to joining Sutro.

Tubulis

Tubulis has appointed Günter Fingerle-Rowson to chief medical officer. Previously, Fingerle-Rowson served as vice president at MorphoSys.

Upcoming Events

  • 17May

    Three Data Trends to Consider Now When Developing Your Decentralized Clinical Trial Strategy

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing